Openbookopenbook
Equity
InfuSystems Holdings Inc(INFU)
USD --+0.00%
Reward71High
Risk35Moderate
📊75%Data
Thin 5% profit margin
INFU
+0.0 · +0.00%
USD · NYSE MKT
InfuSystems Holdings Inc | Healthcare
Quality Compounder
Market Cap:174.85M
ℹ️
Reward Rating
71
High
Top 25% (model universe)
75% data coverage
ℹ️
Risk Rating
35
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on INFU to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $14.90.

What is InfuSystems Holdings Inc?

, through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada.

INFU · Verdict

Strong reward · moderate risk

INFU stands out on balance sheet and cash flow, but watch the volatility signal.

Based on 88% data coverage

INFU · Verdict

What’s working & what to watch

Strengths 5

  • Balance sheet87/100

    Interest covered 9.2×

  • Cash flow87/100

    17% free-cash-flow margin

  • Growth79/100

    Rev +9.3% CAGR · earnings +833.0%

  • Profitability78/100

    10% net margin · 12% ROE

  • Valuation75/100

    P/E 30.0× · PEG 1.22

Watchouts 1

  • Volatility20/100

    Weak vs peers

Model-based scoring. For information only — not financial advice.

What is InfuSystems Holdings Inc?

, through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates in two segments, Patient Services and Device Solutions. The company is listed on the NYSE MKT in USA, operating in the Healthcare sector, with a market capitalisation of 174.85M, and a P/E ratio of 32.9x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Strong margins and consistent earnings support financial stability.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: High (71)

The scoring profile indicates a strong reward potential, driven primarily by growth and profitability. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap174.85M
P/E Ratio32.9231
Dividend YieldN/A
52 Week High11.04
52 Week Low4.61
Last AnnualDecember
IPO Date12/27/2007
IncorporatedUSA
Shares Outstanding20M
No. of Employees502
IndustryMedical Devices
ExchangeNYSE MKT
Beta1.683
CurrencyUSD
Websitewww.infusystem.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.